These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 23558429)

  • 1. Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study.
    Andreasen NC; Liu D; Ziebell S; Vora A; Ho BC
    Am J Psychiatry; 2013 Jun; 170(6):609-15. PubMed ID: 23558429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.
    Ho BC; Andreasen NC; Ziebell S; Pierson R; Magnotta V
    Arch Gen Psychiatry; 2011 Feb; 68(2):128-37. PubMed ID: 21300943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal regional brain volume loss in schizophrenia: Relationship to antipsychotic medication and change in social function.
    Guo JY; Huhtaniska S; Miettunen J; Jääskeläinen E; Kiviniemi V; Nikkinen J; Moilanen J; Haapea M; Mäki P; Jones PB; Veijola J; Isohanni M; Murray GK
    Schizophr Res; 2015 Oct; 168(1-2):297-304. PubMed ID: 26189075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain tissue changes and antipsychotic medication.
    Puri BK
    Expert Rev Neurother; 2011 Jul; 11(7):943-6. PubMed ID: 21721911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.
    Fusar-Poli P; Smieskova R; Kempton MJ; Ho BC; Andreasen NC; Borgwardt S
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1680-91. PubMed ID: 23769814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No progression of the alterations in the cortical thickness of individuals with schizophrenia-spectrum disorder: a three-year longitudinal magnetic resonance imaging study of first-episode patients.
    Roiz-Santiáñez R; Ortiz-García de la Foz V; Ayesa-Arriola R; Tordesillas-Gutiérrez D; Jorge R; Varela-Gómez N; Suárez-Pinilla P; Córdova-Palomera A; Navasa-Melado JM; Crespo-Facorro B
    Psychol Med; 2015 Oct; 45(13):2861-71. PubMed ID: 26004991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain volume changes in first-episode schizophrenia: a 1-year follow-up study.
    Cahn W; Hulshoff Pol HE; Lems EB; van Haren NE; Schnack HG; van der Linden JA; Schothorst PF; van Engeland H; Kahn RS
    Arch Gen Psychiatry; 2002 Nov; 59(11):1002-10. PubMed ID: 12418933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain morphometry of individuals with schizophrenia with and without antipsychotic medication – The Northern Finland Birth Cohort 1966 Study.
    Moilanen J; Huhtaniska S; Haapea M; Jääskeläinen E; Veijola J; Isohanni M; Koponen H; Miettunen J
    Eur Psychiatry; 2015 Jul; 30(5):598-605. PubMed ID: 25791180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of paliperidone palmitate one-month formulation on relapse prevention in patients with schizophrenia: A post-hoc analysis of a one-year, open-label study stratified by medication adherence.
    Si T; Li N; Lu H; Cai S; Zhuo J; Correll CU; Zhang L; Feng Y
    J Psychopharmacol; 2018 Jun; 32(6):691-701. PubMed ID: 29764266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment.
    McClure RK; Carew K; Greeter S; Maushauer E; Steen G; Weinberger DR
    Schizophr Res; 2008 Jan; 98(1-3):29-39. PubMed ID: 17976957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia.
    Andreasen NC; Nopoulos P; Magnotta V; Pierson R; Ziebell S; Ho BC
    Biol Psychiatry; 2011 Oct; 70(7):672-9. PubMed ID: 21784414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia.
    Ho BC; Andreasen NC; Nopoulos P; Arndt S; Magnotta V; Flaum M
    Arch Gen Psychiatry; 2003 Jun; 60(6):585-94. PubMed ID: 12796222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies.
    Vita A; De Peri L; Deste G; Barlati S; Sacchetti E
    Biol Psychiatry; 2015 Sep; 78(6):403-12. PubMed ID: 25802081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confounders of excessive brain volume loss in schizophrenia.
    Van Haren NE; Cahn W; Hulshoff Pol HE; Kahn RS
    Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 1):2418-23. PubMed ID: 23000300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings.
    Navari S; Dazzan P
    Psychol Med; 2009 Nov; 39(11):1763-77. PubMed ID: 19338710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alcohol consumption and antipsychotic medication on brain morphology in schizophrenia.
    Nesvåg R; Frigessi A; Jönsson EG; Agartz I
    Schizophr Res; 2007 Feb; 90(1-3):52-61. PubMed ID: 17218084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication.
    Veijola J; Guo JY; Moilanen JS; Jääskeläinen E; Miettunen J; Kyllönen M; Haapea M; Huhtaniska S; Alaräisänen A; Mäki P; Kiviniemi V; Nikkinen J; Starck T; Remes JJ; Tanskanen P; Tervonen O; Wink AM; Kehagia A; Suckling J; Kobayashi H; Barnett JH; Barnes A; Koponen HJ; Jones PB; Isohanni M; Murray GK
    PLoS One; 2014; 9(7):e101689. PubMed ID: 25036617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain volume changes after withdrawal of atypical antipsychotics in patients with first-episode schizophrenia.
    Boonstra G; van Haren NE; Schnack HG; Cahn W; Burger H; Boersma M; de Kroon B; Grobbee DE; Hulshoff Pol HE; Kahn RS
    J Clin Psychopharmacol; 2011 Apr; 31(2):146-53. PubMed ID: 21346618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
    Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
    J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.